Sometimes you just can’t see the wood from the trees. Teams gets so focussed on the technology or treatment you’re selling ...

LEO Pharma has shared final results from a long-term extension study of its atopic dermatitis (AD) drug Adbry ...

Knowing this, it amazes me how many pharmaceutical organisations of all sizes are missing the mark on key areas of launch ...

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more ...

Every year, the medical community recognizes the month of November as Clostridioides difficile (C. diff) Awareness month. C. diff is a public health threat that causes around 500,000 infections every ...

Generative AI platforms are revolutionizing drug discovery, driving significant biopharma dealmaking by enabling the design of innovative small-molecule and biologic drug candidates. The launch of ...

Johnson & Johnson (J&J) has shared positive results from a late-stage study of its dual-acting IL-23 inhibitor Tremfya (guselkumab) in plaque psoriasis patients. The phase 3b SPECTREM trial has been ...

After the recent Paralympics, I can’t help but be in awe of the individuals who participated and achieved such amazing feats, despite having everyday challenges most of us can hardly comprehend. It is ...

Serving up customer experience excellence - PMLiVE ...

Pfizer’s Elrexfio (elranatamab) has been recommended with managed access by the National Institute for Health and Care Excellence (NICE) to treat relapsed and refractory multiple myeloma in adults.

Eli Lilly has shared positive results from a late-stage study of its amyloid plaque-targeting Alzheimer’s disease (AD) drug donanemab in adults with early symptomatic cases of the neurodegenerative ...

Eloise Moffett, Innovative Trials’ Vice President of Commercial, reflects on how the company’s growing presence in the US is transforming client relationships and its ability to provide the best ...